Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Payables (2016 - 2025)

National Healthcare's Payables history spans 16 years, with the latest figure at $32.7 million for Q4 2025.

  • For Q4 2025, Payables fell 6.32% year-over-year to $32.7 million; the TTM value through Dec 2025 reached $32.7 million, down 6.32%, while the annual FY2025 figure was $32.7 million, 6.32% down from the prior year.
  • Payables reached $32.7 million in Q4 2025 per NHC's latest filing, up from $25.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $35.0 million in Q2 2022 to a low of $23.3 million in Q1 2025.
  • Average Payables over 5 years is $27.7 million, with a median of $25.7 million recorded in 2022.
  • Peak YoY movement for Payables: soared 40.15% in 2022, then fell 29.37% in 2023.
  • A 5-year view of Payables shows it stood at $26.1 million in 2021, then dropped by 2.72% to $25.4 million in 2022, then increased by 11.29% to $28.2 million in 2023, then increased by 23.61% to $34.9 million in 2024, then decreased by 6.32% to $32.7 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's Payables are $32.7 million (Q4 2025), $25.0 million (Q3 2025), and $31.2 million (Q2 2025).